This Thursday we should see $95+. CELG has a lot going for it and analysts will continue to jump on board. Analysts think earnings will be in line and forward guidance raised. I see $125.0 to $150 sometime next year. Textbook buy or add in here my friends.
Sentiment: Strong Buy
CELG reports on Thursday, but on Tues or Wen we will hear Phase 2 data on GED-301. If there is any market caused weakness this week, We want to be buyers. I think GED-301 could be CELG's next Revilimid.
Nice analysis. I bought in about 1.5 years ago and am holding for the long pull. The real key here is that the management really know what they are doing. 5 years from now CELG owners won,t even remember this sell off. They will be too bust dancing in the street because of the price.
CELG has now drivers on its drugs until we hear about GED-301 next week. CELG already released 4 new drugs in the past year. The earnings are more predictable and there are no surprises until they announce something new.
but celg has a much higher pe than gild, given the fact that gild's main income is from hiv + hep c, and celg has a much more diversified pipeline, given a higher pe of celg, celg share price should be up as much as gild or more.
Gild has a higher growth rate but that growth is dependent on just its Hep C drug. That is why GILD is capable of big up days and just as big down days. whenever something comes out about competition GILD gets hit hard. When all is quiet it goes up.
have both + regn + amgn...it's just not sure how to read sometimes, that's why i am looking for some answers to understand more...
You forgot to say also that stupid program selling and ETF program selling is mindlessly creating a super buy in CELG.
Hopefully soon, but we're at a confluence of both rational and irrational fears. The rational fears are that Europe pulls the rest of the world into recession. Germany now that the slowdown is hitting it hard might finally be ready to stimulate their economy some, they didn't give a fart when the rest of Europe was struggling, but now that it's hitting them it looks like they might change their tune.
The other rational fear is the one spreading among the hedge fund community that found itself on the wrong side of the oil trade and the bond trade. These 3:30 pm selloffs are directly related to margin calls for the hedgies. I fail to see how you can call yourself a hedge fund by following the pack of other hedgies all betting the same direction and crowding into the same trades.
And the irrational fear is Ebola. The market cannot parse irrational fears (the next black death), hopefully our health care system gets it act together and we both contain the outbreak here in the U.S. and the world finally decides that letting high mortality contagious diseases go unchecked in Africa and other 3rd world countries is not a good thing and invests a few bucks in some vaccine research.
I added more at $84.5 early this morning. Looking back in a couple years, it will be a brilliant move and I will kiss myself:)
AGIO starting new AML trials in PH1 as added Cohorts. Data must be stellar. This is great news for CELG, because of their partnership agreement.